<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>30(24)</volume><submitter>Bakirova RY</submitter><pubmed_abstract>An important aspect of food technology is that vitamin compounds can be used for a variety of purposes, such as developing methods to enhance the nutritional value of foods. This paper discusses the synthesis and properties of β-cyclodextrin (β-CD)-functionalized silver nanoparticles, and the use of the resulting β-CD-AgNP inclusion complex when loading vitamin D&lt;sub>3&lt;/sub> (cholecalciferol, VD&lt;sub>3&lt;/sub>) molecules. β-Cyclodextrin was used as a reducing agent and a stabilizer in the production of silver nanoparticles. The preparation of VD&lt;sub>3&lt;/sub>-β-CD-AgNP nanocompositions was confirmed by UV spectroscopy, transmission electron microscopy, and X-ray diffraction spectroscopy. Scanning electron microscopy (SEM) and transmission electron microscopy (TEM) revealed that the resulting β-CD-VD&lt;sub>3&lt;/sub>-AgNP nanocomposite was well dispersed with particle sizes ranging from 6 to 15 nm. &lt;sup>1&lt;/sup>H-, &lt;sup>13&lt;/sup>C-NMR and FTIR spectroscopy showed the reduction of silver ions and the formation of β-CD-encapsulated AgNPs. The kinetic parameters of the thermal decomposition reaction of the VD&lt;sub>3&lt;/sub>-β-CD-AgNP nanocomposition have been determined under nonisothermal conditions that ensure the preservation of the kinetic triplet and a more accurate description of the process. The nanocomposition of VD&lt;sub>3&lt;/sub> with silver nanoparticles demonstrated antibacterial activity against the used bacteria.</pubmed_abstract><journal>Molecules (Basel, Switzerland)</journal><pagination>4823</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12735546</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Preparation of a Supramolecular Assembly of Vitamin D in a β-Cyclodextrin Shell with Silver Nanoparticles.</pubmed_title><pmcid>PMC12735546</pmcid><pubmed_authors>Agedilova MT</pubmed_authors><pubmed_authors>Ashirbekova BD</pubmed_authors><pubmed_authors>Mendibayeva AZ</pubmed_authors><pubmed_authors>Sviderskiy AK</pubmed_authors><pubmed_authors>Mustafayeva AK</pubmed_authors><pubmed_authors>Khabdolda G</pubmed_authors><pubmed_authors>Bakirova RY</pubmed_authors><pubmed_authors>Iskineyeva AS</pubmed_authors><pubmed_authors>Fazylov SD</pubmed_authors><pubmed_authors>Sarsenbekova AZ</pubmed_authors><pubmed_authors>Seilkhanov OT</pubmed_authors></additional><is_claimable>false</is_claimable><name>Preparation of a Supramolecular Assembly of Vitamin D in a β-Cyclodextrin Shell with Silver Nanoparticles.</name><description>An important aspect of food technology is that vitamin compounds can be used for a variety of purposes, such as developing methods to enhance the nutritional value of foods. This paper discusses the synthesis and properties of β-cyclodextrin (β-CD)-functionalized silver nanoparticles, and the use of the resulting β-CD-AgNP inclusion complex when loading vitamin D&lt;sub>3&lt;/sub> (cholecalciferol, VD&lt;sub>3&lt;/sub>) molecules. β-Cyclodextrin was used as a reducing agent and a stabilizer in the production of silver nanoparticles. The preparation of VD&lt;sub>3&lt;/sub>-β-CD-AgNP nanocompositions was confirmed by UV spectroscopy, transmission electron microscopy, and X-ray diffraction spectroscopy. Scanning electron microscopy (SEM) and transmission electron microscopy (TEM) revealed that the resulting β-CD-VD&lt;sub>3&lt;/sub>-AgNP nanocomposite was well dispersed with particle sizes ranging from 6 to 15 nm. &lt;sup>1&lt;/sup>H-, &lt;sup>13&lt;/sup>C-NMR and FTIR spectroscopy showed the reduction of silver ions and the formation of β-CD-encapsulated AgNPs. The kinetic parameters of the thermal decomposition reaction of the VD&lt;sub>3&lt;/sub>-β-CD-AgNP nanocomposition have been determined under nonisothermal conditions that ensure the preservation of the kinetic triplet and a more accurate description of the process. The nanocomposition of VD&lt;sub>3&lt;/sub> with silver nanoparticles demonstrated antibacterial activity against the used bacteria.</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Dec</publication><modification>2026-06-10T03:08:15.514Z</modification><creation>2026-06-10T03:07:03.394Z</creation></dates><accession>S-EPMC12735546</accession><cross_references><pubmed>41471844</pubmed><doi>10.3390/molecules30244823</doi></cross_references></HashMap>